AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2013
Jun 5, 2013
29828_dirs_2013-06-05_6cd7b046-b8fe-4688-b9fd-86cdf5f63193.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-06-03
Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-03 | Common Stock | M | 282242 | $7.6325 | Acquired | 4339363 | Direct |
| 2013-06-03 | Common Stock | S | 28200 | $51.9120 | Disposed | 4311163 | Direct |
| 2013-06-03 | Common Stock | S | 225700 | $52.7984 | Disposed | 4085463 | Direct |
| 2013-06-03 | Common Stock | S | 24800 | $53.9920 | Disposed | 4060663 | Direct |
| 2013-06-03 | Common Stock | S | 3542 | $54.5884 | Disposed | 4057121 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-03 | Non-Qualified Stock option (right to buy) | $7.6325 | M | 282242 | Disposed | 2014-01-28 | Common Stock (282242) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $51.42 to $52.42. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $52.43 to $53.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $53.46 to $54.44. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $54.55 to $54.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.